Business Acquisitions

6 Months Ended

Feb. 29, 2012

Notes to Financial Statements [Abstract]

Acquisitions

Note 13.  Acquisitions

The aggregate purchase price of all business and intangible asset acquisitions was $204 million for the six months ended February 29, 2012 and includes primarily prescription files along with the purchase of Crescent Pharmacy Holdings, LLC, an infusion pharmacy business, for $75 million, net of assumed cash.  These acquisitions added $37 million to goodwill and $125 million to intangible assets, primarily prescription files.  The remaining fair value relates to immaterial amounts of tangible assets, less liabilities assumed.  Operating results of the businesses acquired have been included in the Consolidated Condensed Statements of Earnings from their respective acquisition dates forward.  Pro forma results of the Company, assuming all of the acquisitions had occurred at the beginning of each period presented, would not be materially different from the results reported.